Short Communication: Differences in 5-Year Survival After Cancer Diagnosis Between HIV Clinic Enrollees and the General U.S. Population.
CD4
HIV infection
cancer
cancer survival
Journal
AIDS research and human retroviruses
ISSN: 1931-8405
Titre abrégé: AIDS Res Hum Retroviruses
Pays: United States
ID NLM: 8709376
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
5
11
2019
medline:
12
1
2021
entrez:
5
11
2019
Statut:
ppublish
Résumé
A total of 236 people with HIV (PWH) with cancer diagnosed between 1997 and 2014 in the Johns Hopkins HIV Clinical Cohort (JHHCC) were compared with a sample from NCI's Surveillance, Epidemiology, and End Results (SEER) Program, presumed to be HIV negative. Using G-computation with random survival forest methods, we estimated 5-year restricted mean survival time (RMST) differences by HIV status. Sensitivity analyses were performed among non-AIDS defining cancers, males, females, and stratifying PWH by CD4 ≤ 200 or >200 cells/mm
Identifiants
pubmed: 31679394
doi: 10.1089/AID.2019.0145
pmc: PMC7044775
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
116-118Subventions
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI069918
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036935
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146193
Pays : United States
Références
Cancer. 2015 Jun 15;121(12):2063-71
pubmed: 25739496
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1167-73
pubmed: 25713023
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1027-1033
pubmed: 28619832
BMC Med Res Methodol. 2013 Dec 07;13:152
pubmed: 24314264
AIDS. 2011 Mar 13;25(5):691-700
pubmed: 21160411
J Clin Oncol. 2014 Aug 1;32(22):2344-50
pubmed: 24982448
Am J Epidemiol. 2011 Apr 1;173(7):731-8
pubmed: 21415029
Am J Epidemiol. 2011 Oct 1;174(7):860-70
pubmed: 21821540